DOKTERS BUYSE-KENIS
0452.360.290 · rovalta.com · 26/09/2026
DOKTERS BUYSE-KENIS
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODOKTERS BUYSE-KENIS is a Private limited company incorporated in 1994. Its main activity is: Other human health activities. Its registered office is in Menen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0452.360.290
- Incorporation
- 21/03/1994
- Legal form
- Private limited company
- Registered office
- Spoorwegstraat 114
8930 Menen · FlandreSee on map - Contributed capital
- 18 592,01 €
- Latest accounts
- 30/09/2025
Joint committees (1)
- 330
Financials
Source · NBB, 20 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 67,1 k € | -29.1% | 94,6 k € | +128% | 41,4 k € | -48.1% | 79,8 k € | -42.6% | 139 k € |
| EBITDA | 66,1 k € | -29.4% | 93,7 k € | +128% | 41 k € | -37.3% | 65,4 k € | -32.8% | 97,4 k € |
| Operating result | 53,7 k € | -29.5% | 76,2 k € | +187% | 26,5 k € | -14.4% | 31 k € | -50.9% | 63,1 k € |
| Net result | 37,2 k € | -29.5% | 52,8 k € | +224% | 16,3 k € | -17.4% | 19,8 k € | -56.2% | 45,1 k € |
| Balance sheet | |||||||||
| Equity | 186,9 k € | +23.5% | 151,4 k € | +51.0% | 100,3 k € | -3.3% | 103,7 k € | +23.5% | 84 k € |
| Total assets | 210,1 k € | +10.3% | 190,5 k € | +36.4% | 139,7 k € | -11.0% | 157 k € | -2.3% | 160,7 k € |
| Cash | 71,9 k € | -23.7% | 94,2 k € | +242% | 27,6 k € | -50.0% | 55,1 k € | -14.3% | 64,3 k € |
| Debts | 23,3 k € | -40.6% | 39,1 k € | +1.9% | 38,4 k € | -21.5% | 48,9 k € | -35.1% | 75,3 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20252 active · 4 ended
Active mandates
Ended mandates
Other companies at this address
Spoorwegstraat 114 8930 Menen| Company | CBE no. |
|---|---|
Medisch Huis De Statie● Active | 0767.693.830 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/04/2026 | 16/04/2025 | 30/04/2024 | 27/04/2023 | 28/04/2022 | 14/04/2021 |
| General meeting | 31/03/2026 | 24/03/2025 | 30/03/2024 | 31/03/2023 | 31/03/2022 | 26/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 31/03/2026 | 29/04/2026 | Dutch | |
| Micro model | 30/09/2024 | 24/03/2025 | 16/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 30/03/2024 | 30/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 31/03/2023 | 27/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 31/03/2022 | 28/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 26/03/2021 | 14/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 28/02/2020 | 07/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 05/01/2019 | 12/04/2019 | Dutch | |
| Micro model | 30/09/2017 | 19/02/2018 | 23/04/2018 | Dutch | |
| Abridged model | 30/09/2016 | 04/02/2017 | 20/03/2017 | Dutch | |
| Abridged model | 30/09/2015 | 29/02/2016 | 30/03/2016 | Dutch | |
| Abridged model | 30/09/2014 | 27/01/2015 | 27/03/2015 | Dutch | |
| Abridged model | 30/09/2013 | 24/02/2014 | 20/03/2014 | Dutch | |
| Abridged model | 30/09/2012 | 05/01/2013 | 22/04/2013 | Dutch | |
| Abridged model | 30/09/2011 | 07/01/2012 | 29/02/2012 | Dutch | |
| Abridged model | 30/09/2010 | 03/01/2011 | 02/03/2011 | Dutch | |
| Abridged model | 30/09/2009 | 02/01/2010 | 02/03/2010 | Dutch | |
| Abridged model | 30/09/2008 | 03/01/2009 | 18/03/2009 | Dutch | |
| Abridged model | 30/09/2007 | 05/01/2008 | 25/02/2008 | Dutch | |
| Abridged model | 30/09/2006 | 06/01/2007 | 14/03/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20252 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates13/04/2023WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202537,2 k €↓
- 2024Annual accounts 202452,8 k €↑
- 2023Annual accounts 202316,3 k €↓
- 2022Annual accounts 202219,8 k €↓
- 2022Name changeDOKTERS BUYSE-KENIS
- 2021Annual accounts 202145,1 k €↑
- 2021Name changeBuyse - Kenis Dokters
- 2020Annual accounts 202040,3 k €↑
- 2019Annual accounts 201932,1 k €↑
- 2018Annual accounts 2018-7,6 k €↓
- 2017Annual accounts 201734 k €↑
- 2016Annual accounts 2016799,3 €↓
- 2015Annual accounts 201520,5 k €↓
- 2014Annual accounts 201424,9 k €↑
- 2013Annual accounts 201324,5 k €↑
- 2012Annual accounts 2012-3,6 k €
- 21/03/1994IncorporationPrivate limited company